DrPablo Alexandre Mallaroni

My key interest is demystifying altered states of consciousness for clinical use. To this end, I leverage computational neuroscience approaches to design and run ultra-high field multimodal pharmacoimaging trials. Combining large-scale modelling, connectomics, complexity science, behavioural and metabolomic data, the aim is to develop predictive mechanistic models of self-dissolution and recovery to guide personalised psychedelic treatment plans.